EVGN Evogene Ltd Ord

NASDAQ
$0.43

Evogene Ltd Ord (EVGN) is expected to report earnings on November 17, 2026, before the market open. The consensus earnings estimate is a loss of $0.19 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -24.1% since its last earnings release on August 18, 2026.

Evogene Ltd Ord Reported Earnings
Tuesday, August 18, 2026 · 8:04 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 17
Tuesday · 7:00 AM ET
Earnings Whisper
-
vs ($0.19)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Evogene Ltd Ord

Evogene Ltd. is a developer of improved plant traits. It develops genetically modified agricultural crops, molecular markers to assist breeding and a protein farming platform for the pharmaceutical industry.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.